Consolidated Statements of Cash Flows (Unaudited) (USD $) In Millions, unless otherwise specified	6 Months Ended
	Sep. 28, 2013	Sep. 29, 2012
Cash flows from operating activities:
Net income	$ 386	$ 407
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization expense	126	113
Deferred income tax expense (benefit)	(16)	5
Equity in losses (gains) of equity-method investees	5	3
Non-cash stock-based compensation expense	43	43
Gain on acquisition of Chaps	(16)	0
Excess tax benefits from stock-based compensation arrangements	(20)	(26)
Other non-cash charges (benefits), net	0	(1)
Changes in operating assets and liabilities:
Accounts receivable	(93)	(56)
Inventories	(271)	(216)
Accounts payable and accrued liabilities	61	37
Income tax receivables and payables	(12)	(10)
Deferred income	(11)	(16)
Other balance sheet changes, net	38	24
Net cash provided by (used in) operating activities	220	307
Cash flows from investing activities:
Acquisitions and ventures, net of cash acquired and purchase price settlements	(36)	(10)
Purchases of investments	(644)	(609)
Proceeds from sales and maturities of investments	492	647
Capital expenditures	(214)	(117)
Change in restricted cash deposits	(6)	7
Net cash provided by (used in) investing activities	(408)	(82)
Cash flows from financing activities:
Proceeds from issuance of long-term debt	300	0
Payments of capital lease obligations	(5)	(4)
Payments of dividends	(73)	(55)
Repurchases of common stock, including shares surrendered for tax withholdings	(210)	(347)
Prepayments of Common Stock Repurchases		26
Proceeds from exercise of stock options	19	26
Excess tax benefits from stock-based compensation arrangements	20
Net cash provided by (used in) financing activities	51	(354)
Effect of exchange rate changes on cash and cash equivalents	2	1
Net increase (decrease) in cash and cash equivalents	(135)	(128)
Cash and cash equivalents at beginning of period	974	672
Cash and cash equivalents at end of period	$ 839	$ 544